Paroxetine controlled-release: benefits in fibromyalgia

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1438, 2004-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paroxetine Controlled Release

By Bang L.M. Keating G.M.

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 355-364

Adis International

Access to resources Recommend Favorite

In Canada, a Public Advisory warning against the concomitant use of Paxil [paroxetine] or Paxil controlled-release (CR) and Orap [pimozide]

Reactions Weekly, Vol. 1, Iss. 1063, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Health Canada has approved GlaxoSmithKline's controlled-release formulation of paroxetine

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Paroxetine Controlled Release: A Viewpoint by Ben Green

By Green B.

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 365-366

Adis International

Access to resources Recommend Favorite

Controlled-Release Carvedilol

By Carter Natalie J. Keating Gillian M.

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 4, 2008-01 ,pp. : 271-282

Adis International

Access to resources Recommend Favorite